Tumoral samples from B-NHL patients, including FL, DLBCL, MCL, MZL and CLL, present overexpression of TIGIT in CD4+ and CD8+ T-cells, which produce lower levels of proinflammatory cytokines as well as expression of the ligand CD155 in the TME [291]. The gene discussed is CD8A; the disease is neoplasm.